Ursprung des Netzwerks ersten Grades von Audrey Rossow
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Audrey Rossow
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member President | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Advanced Inhalation Research, Inc. is a company that develops dry-powder drug delivery systems for respiratory patients. The company is based in Cambridge, MA. The company was founded by Terrance G. McGuire, Justin S. Hanes. Advanced Inhalation Research was acquired by Alkermes, Inc., part of Alkermes Plc from September 16, 2011 on February 01, 1999 for $114.54 million. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
INVIVYD, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
ZURA BIO LIMITED | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
KALA BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
Faraday Pharmaceuticals, Inc. (Washington)
Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Drugstore Chains | Director/Board Member Director/Board Member | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Founder Chief Executive Officer | |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onebiopharma, Inc.
Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Onebiopharma, Inc. provides health care services. The company is headquartered in Boston, MA. | Medical/Nursing Services | Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Chairman | |
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IV | Financial Conglomerates | Director/Board Member | |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor | |
Renagade Therapeutics, Inc.
Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Chief Executive Officer | |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Orna Therapeutics, Inc. is a biotechnology company that designs and delivers fully engineered circular RNA therapeutics to treat diseases. Orna Therapeutics is based in Cambridge, MA, and has subsidiaries in the United States. The company's proprietary platform combines novel technology to create RNA that drives protein expression with validated and unique delivery solutions. Orna has many advantages over traditional approaches, including simplified production, improved formulatability, and superior protein expression. The company was founded by Daniel Anderson, Raffaella Squilloni, Alex Wesselhoeft, and the CEO is Thomas M. Barnes. | Biotechnology | Chief Executive Officer | |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ball State University (Indiana) | College/University | Undergraduate Degree | |
SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MERUS N.V. | Biotechnology | Director/Board Member | |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Wellesley Youth Hockey Association
Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Wellesley Youth Hockey Association is a sports organization that promotes ice hockey and values such as sportsmanship, teamwork, and respect for the rules of play. The association is based in Wellesley, Massachusetts. The association offers various programs for different age groups, including travel teams, mite programs, and goalie training. It also provides resources for coaches, officials, and parents. | Movies/Entertainment | Director/Board Member | |
Peter F Drucker & Masatoshi Ito Graduate School of Management | College/University | Masters Business Admin | |
Nephrian, Inc. | Founder | ||
Cytrellis Biosystems, Inc.
Cytrellis Biosystems, Inc. Medical SpecialtiesHealth Technology Cytrellis Biosystems, Inc. designs and develops aesthetic devices. The company was founded by William Gerald Austen and Doug A. Levinson and is headquartered in Boston, MA. | Medical Specialties | Chairman | |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
APEXIGEN, INC. | Biotechnology | Director of Finance/CFO | |
University of Calgary | College/University | Undergraduate Degree | |
ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
Georgetown University School of Medicine | College/University | Doctorate Degree | |
Veristat LLC
Veristat LLC BiotechnologyHealth Technology Veristat LLC engages in the provision of statistical and medical consulting services to the pharmaceutical and biotechnology industries. Its services include data management, biostatistics, statistical programming, medical writing, clinical monitoring, project management, regulatory submissions, and strategic consulting. The company was founded by Barbara Balser and John P. Balser in 1994 and is headquartered in Southborough, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistik
International
Vereinigte Staaten | 45 |
Vereinigtes Königreich | 3 |
Schweiz | 2 |
Japan | 2 |
Niederlande | 2 |
Sektoral
Health Technology | 37 |
Consumer Services | 8 |
Finance | 4 |
Retail Trade | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 131 |
Chairman | 39 |
Corporate Officer/Principal | 36 |
Independent Dir/Board Member | 33 |
Chief Tech/Sci/R&D Officer | 27 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Steven Gillis | 58 |
Terry McGuire | 51 |
Amit Munshi | 27 |
Mark Iwicki | 26 |
Matthew Sherman | 16 |
Christopher Cabell | 16 |
Peter Ludlum | 14 |
William Duke | 11 |
James M. Roach | 11 |
Robert Clarke | 11 |
Richard Batycky | 9 |
Anand Varadan | 9 |
Margaret Wasilewski | 8 |
Todd Bazemore | 7 |
- Börse
- Insiders
- Audrey Rossow
- Unternehmensverbindungen